Studies on hyaline membrane disease. V. Oxygen induced hyaline membrane disease in guinea pigs.
D000614:Aminocaproates / Q000627:therapeutic use*; D000653:Amniotic Fluid; D000818:Animals; D007611:Aprotinin / Q000627:therapeutic use*; D005260:Female; D005341:Fibrinolysin / Q000627:therapeutic use*; D006168:Guinea Pigs; D006801:Humans; D006819:Hyaline Membrane Disease / Q000139:chemically induced* / Q000188:drug therapy* / Q000473:pathology*; D007231:Infant, Newborn; D008168:Lung / Q000187:drug effects* / Q000473:pathology*; D010100:Oxygen; D011427:Propiophenones / Q000627:therapeutic use*; D000338:beta-Aminoethyl Isothiourea / Q000627:therapeutic use*
D000614:Aminocaproates; D011427:Propiophenones; D000338:beta-Aminoethyl Isothiourea; D007611:Aprotinin; D005341:Fibrinolysin; D010100:Oxygen